Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMA
2151
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.85M | ﹤0.01% |
574,340
+7,917
| +1% | +$41.2K |
|
|
GLUU
2152
DELISTED
Glu Mobile Inc.
GLUU
| $2.85M | ﹤0.01% |
470,900
+455,700
| +2,998% | +$2.6M |
|
|
GIFI
2153
DELISTED
Gulf Island Fabrication
GIFI
| $2.84M | ﹤0.01% |
560,453
+225,224
| +67% | +$1.15M |
|
|
EEX
2154
DELISTED
Emerald Holding
EEX
| $2.84M | ﹤0.01% |
269,142
+18,742
| +7% | +$186K |
|
|
IEC
2155
DELISTED
IEC Electronics Corp.
IEC
| $2.84M | ﹤0.01% |
312,069
+9,248
| +3% | +$70.1K |
|
2156
Urban One Class D
UONEK
$23.4M
| $2.84M | ﹤0.01% |
149,255
+890
| +0.6% | +$18.2K |
|
2157
Minerals Technologies
MTX
$2.27B
| $2.83M | ﹤0.01% |
49,100
-62,100
| -56% | -$3.34M |
|
2158
Data I/O
DAIO
$32.4M
| $2.83M | ﹤0.01% |
665,108
+6,194
| +0.9% | +$24.8K |
|
2159
BJ's Restaurants
BJRI
$1.45B
| $2.82M | ﹤0.01% |
+74,329
| New | +$2.85M |
|
|
CDMO
2160
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.82M | ﹤0.01% |
367,590
+186,584
| +103% | +$1.09M |
|
|
SRGA
2161
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.82M | ﹤0.01% |
34,293
-4,493
| -12% | -$315K |
|
2162
Identive
INVE
$64.1M
| $2.82M | ﹤0.01% |
499,432
+60,671
| +14% | +$307K |
|
2163
Unilever
UL
$134B
| $2.81M | ﹤0.01% |
43,644
-71,823
| -62% | -$4.77M |
|
|
ITCL
2164
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $2.8M | ﹤0.01% |
325,166
+1,966
| +0.6% | +$17.6K |
|
|
AGNT
2165
AGNT Inc
AGNT
$727M
| $2.8M | ﹤0.01% |
494,058
+317,800
| +180% | +$1.58M |
|
2166
iShares MSCI ACWI ETF
ACWI
$33.6B
| $2.8M | ﹤0.01% |
+35,300
| New | +$2.7M |
|
2167
First Bank
FRBA
$471M
| $2.79M | ﹤0.01% |
252,595
+27,410
| +12% | +$297K |
|
2168
International Seaways
INSW
$4.81B
| $2.79M | ﹤0.01% |
93,700
+33,500
| +56% | +$873K |
|
|
WCC
2169
WESCO International
WCC
$17.6B
| $2.79M | ﹤0.01% |
46,900
-8,500
| -15% | -$443K |
|
2170
Terreno Realty
TRNO
$7.43B
| $2.78M | ﹤0.01% |
51,400
-47,800
| -48% | -$2.61M |
|
|
TCFC
2171
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $2.77M | ﹤0.01% |
78,014
+7,500
| +11% | +$254K |
|
|
SYNC
2172
DELISTED
Synacor, Inc.
SYNC
| $2.77M | ﹤0.01% |
1,822,812
+93,726
| +5% | +$147K |
|
|
MINI
2173
DELISTED
Mobile Mini Inc
MINI
| $2.76M | ﹤0.01% |
72,770
+16,700
| +30% | +$630K |
|
|
CLPR
2174
Clipper Realty
CLPR
$54M
| $2.74M | ﹤0.01% |
258,657
+3,300
| +1% | +$31.5K |
|
2175
Comp X International
CIX
$385M
| $2.74M | ﹤0.01% |
187,700
+7,800
| +4% | +$114K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.